Pathology
 |
|
12 january 2019 11:00:21 |
| Commentary on `Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma` by Giovanni Barosi and Robert Peter Gale (Leukemia) |
|
Tweet |
| 82 viewsCategory: Pathology |
 NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia (Leukemia)Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL (Leukemia) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
